No clue mopar, and another shining example of how IPCI mgmt. themselves should be informing the market how the ongoing MNK attempted generics division sale drama effects their licensing deal with them!
IPCI mgmt. never takes any time whatsoever to even grant independent interviews with anyone to even attempt to shed any light on any of the murky issues that could definitely benefit from them at least trying to shed fresh light on all their still evolving growth dynamics in play on a constant basis.
The original CFO Shameze Rampertaub was a master at constantly ensuring that IPCI's evolving story was constantly being presented to independent bloggers, journalists etc...and by doing so IPCI had a tremendous amount of fundamental and technical followers back then who would play this stock based on the constant flow of information that Shameze was always providing. Hell even Dr. Odidi used to do interviews and try to ensure that IPCI's still evolving story was constantly being presented...but from the moment Shameze parted the IPCI scene their attention to storyline presentation details has been downright atrocious to say the least.
They couldn't even be bothered properly preparing for last July's Rexista AdCom despite receiving several warnings from their own core shareholders for months in advance that the AdCom panel was gonna be putting them through the ringer and therefore it was encumbent on them to be fully prepared. Instead we saw IPCI's assembled AdCom team fumble their way through the entire afternoon to the point that even their stellar IV abuse deterrent features weren't presented properly...which was the 1 thing their presentation team should've been beyond prepared to shine on.
News 
Market Data 
Discover 
